Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Approves First Treatment for Rare Thyroid Hormone Disorder

(MedPage Today) -- The FDA approved tiratricol (Emcitate) to treat peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency, the agency announced on Monday, marking the first approval for this rare genetic disorder...

FDA Approves First Treatment for Rare Thyroid Hormone Disorder

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 29 September →